首页|透骨血竭散对类风湿关节炎小鼠JAK2/STAT3信号通路及Th17/Treg失衡的影响

透骨血竭散对类风湿关节炎小鼠JAK2/STAT3信号通路及Th17/Treg失衡的影响

扫码查看
目的:探索透骨血竭散对类风湿关节炎(rheumatoid arthritis,RA)小鼠Janus激酶2(Janus kinase 2,JAK2)/信号传导及转录激活蛋白 3(signal transducer and activator of transcription 3,STAT3)信号通路及调节性 T 细胞(regulatory T cells,Treg)/辅助性T细胞17(T helper cell 17,Th17)失衡的影响。方法:急性口服毒性实验:30只C57BL/6小鼠随机分为对照组和5个处理组,每组5只;对照组小鼠灌胃无菌过滤水,处理组小鼠以不同剂量透骨血竭散灌胃(55 mg·kg-1、175 mg·kg-1、550 mg·kg-1、1 750 mg·kg-1、5 000 mg·kg-1),每日1次,连续14 d。采用概率加权回归法(Bliss法)计算小鼠半数致死量(median lethal dose,LD50)和95%置信区间。亚急性毒性实验:20只C57BL/6小鼠随机分为空白组和3个处理组,每组5只;空白组小鼠灌胃无菌过滤水,处理组小鼠以不同剂量透骨血竭散灌胃(500 mg·kg-1、1 000 mg·kg-1、1 500 mg·kg-1),连续28 d,每天观察小鼠的中毒症状。从30只C57BL/6小鼠中随机选取10只作为正常组,其余小鼠注射鸡Ⅱ型胶原蛋白(弗氏完全佐剂乳化);第21天,继续注射鸡Ⅱ型胶原蛋白(弗氏不完全佐剂乳化)增强1次,从而建立关节炎模型。第27天,将造模成功的小鼠随机分为模型组、透骨血竭散组(1 500 mg·kg-1),每组10只,连续灌胃5周,每日1次。采用流式细胞术检测脾脏Treg、Th17细胞数量,Western blot检测滑膜组织JAK2、p-JAK2、STAT3、p-STAT3表达水平,ELISA检测滑膜组织肿瘤坏死因子α(tumor necrosis factor alpha,TNF-α)、白细胞介素-1 β(interleukin-1β,IL-1β)、白细胞介素-17(interleukin-17,IL-17)、白细胞介素-10(interleukin-10,IL-10)含量,并进行关节炎评分(arthritis score,AS)。结果:透骨血竭散的LD50为3 878 mg·kg-1,95%置信区间为1 470~5 498 mg·kg-1。空白组和透骨血竭散各剂量组小鼠均未见死亡或明显的中毒症状。与正常组比较,模型组小鼠脾脏Treg百分比减少、Th17百分比增加(P<0。01);与模型组比较,透骨血竭散组小鼠脾脏Treg百分比增加、Th17百分比下降(P<0。01)。与正常组比较,模型组小鼠滑膜组织TNF-α、IL-1β、IL-17含量升高且IL-10含量降低(P<0。01);与模型组比较,透骨血竭散组小鼠滑膜组织TNF-α、IL-1β、IL-17含量降低且IL-10含量升高(P<0。01)。与正常组比较,模型组小鼠滑膜组织JAK2、p-JAK2、STAT3、p-STAT3表达水平升高(P<0。05);与模型组比较,透骨血竭散组小鼠滑膜组织JAK2、p-JAK2、STAT3、p-STAT3表达水平降低(P<0。05)。结论:透骨血竭散可改善RA小鼠症状,其机制可能与抑制JAK2/STAT3信号通路激活,调节Th17/Treg平衡,抑制炎症反应有关。
Effect of Tougu Xuejie Powder on JAK2/STAT3 Signaling Pathway and Th17/Treg Imbalance in Rheumatoid Arthritis Mice
Objective:To explore the drug safety of Tougu Xuejie Powder and its effect on the imbalance of Janus kinase 2(JAK2)/sig-nal transducer and activator of transcription 3(STAT3)signaling pathway and regulatory T cells(Treg)/T helper cell 17(Th17)in rheumatoid arthritis(RA)mice.Methods:Acute oral toxicity test:30 C57BL/6 mice were randomly divided into a control group and 5 treatment groups,with 5 mice in each group;The mice in the control group were given a gavage with sterile filtered water,while the mice in the treatment group were given a gavage with different doses of Tougu Xuejie Powder(55 mg·kg-1,175 mg·kg-1,550 mg·kg-1,1 750 mg·kg-1,5 000 mg·kg-1)once a day for 14 consecutive days.Calculate the median lethal dose(LD50)and 95%confidence interval of mice using probability weighted regression(Bliss method).Subacute toxicity test:20 C57BL/6 mice were randomly divided into a blank group and 3 treatment groups,with 5 mice in each group;The blank group mice were given a gavage with sterile filtered wa-ter,while the treatment group mice were given a gavage with different doses of Tougu Xuejie Powder(500 mg·kg-1,1 000 mg·kg-1,1 500 mg·kg-1)for 28 consecutive days,and the poisoning symptoms of the mice were observed daily.Select 10 out of 30 C57BL/6 mice randomly as the normal group and inject remaining mice with chicken type Ⅱ collagen(emulsified with Freund's complete adju-vant)and inject the same material another time on the 21st day to establish an arthritis model.On the 27th day,the successfully mod-eled mice were randomly divided into a model group and a Tougu Xuejie Powder group(1 500 mg·kg-1),with 10 mice in each group.They were orally administered for 5 weeks,once a day.Flow cytometry was used to detect Treg and Th17 in the spleen,and West-ern blot was used to detect the expression levels of JAK2,p-JAK2,STAT3 and p-STAT3 in synovial tissue.ELISA was used to detect tumor necrosis factor alpha(TNF-α),Interleukin-1 β(IL-1 β),Interleukin-17(IL-17)and interleukin-10(IL-10)levels in synovial tissue,and arthritis score(AS)was performed.Results:The LD50 of Tougu Xuejie Powder is 3 878 mg·kg-1,with a 95%confidence interval of 1 470-5 498 mg·kg-1.No death or obvious toxic symptoms were observed in the control group and each dose group of mice treated with Tougu Xuejie Powder.Compared with that of the normal group,the percentage of Treg in the spleen of the model group mice decreased and the percentage of Th 17 increased significantly(P<0.01).Compared with that of the model group,the percentage of Treg in the spleen of mice in the group treated with Tougu Xuejie Powder increased,while the percentage of Th17 de-creased significantly(P<0.01).Compared with that of the normal group,TNF-α,IL-1β,IL-17 content in synovial tissue of model group mice increased while the content of IL-10 decreased significantly(P<0.01).Compared with that of the model group,TNF-α,IL-1β,IL-17 content in synovial tissue of Tougu Xuejie Powder group mice decreased while the content of IL-10 increased signifi-cantly(P<0.01).Compared with that of the normal group,the expression levels of JAK2,p-JAK2,STAT3 and p-STAT3 increased in the synovial tissue of the model group mice significantly(P<0.05).Compared with that of the model group,the expression levels of JAK2,p-JAK2,STAT3 and p-STAT3 in the synovial tissue of mice treated with Tougu Xuejie Powder decreased significantly(P<0.05).Conclusion:Tougu Xuejie Powder can relieve symptoms in RA mice,the mechanism of which may be related to inhibiting the ac-tivation of JAK2/STAT3 signaling pathway,regulating Th17/Treg balance and inhibiting inflammatory response.

rheumatoid arthritisTougu Xuejie PowderJAK2/STAT3 signaling pathwayTh17/Treginflammationmouse

陈杜、邓文雯、姜如、肖智

展开 >

长沙市第三医院中西医结合科,湖南长沙 410035

类风湿关节炎 透骨血竭散 JAK2/STAT3信号通路 Th17/Treg 炎症 小鼠

2025

中医学报
河南中医药大学,中华中医药学会

中医学报

影响因子:1.264
ISSN:1674-8999
年,卷(期):2025.40(1)